Note: Quva Pharma's revenues are gauged from an analysis of company filings.
Quva Pharma's Income Statement (based on Industry Averages)
Quva Pharma P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Quva Pharma is developing and marketing.
Quva Pharma doesn't have any recent trademark applications, indicating Quva Pharma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
QUVA Custom manufacture of medications by pharmaceutical compounders
11/09/2018
QUVA PHARMA THE PERFECT BLEND OF QUALITY AND INNOVATION. Custom manufacture of compounded sterile preparations by pharmaceutical compounders
07/25/2018
THE PERFECT BLEND OF QUALITY AND INNOVATION Custom manufacture of compounded sterile preparations by pharmaceutical compounders
07/25/2018
See all trademarks and details in the Full Report.
Market Share of Quva Pharma's Largest Competitors
A competitive analysis shows these companies are in the same general field as Quva Pharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Quva Pharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Quva Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.